- $2.25bn
- $3.13bn
- $2.72bn
Fortrea slips after new CFO appointment
Brief: Fortrea Names Jason Knoblauch As Chief Financial Officer
Fortrea posts lower-than-expected drop in Q1 revenue
U.S. STOCKS ON THE MOVE-Enovis, Cheniere, Packaging Corp of America
U.S. STOCKS ON THE MOVE-Qnity, J.M. Smucker, Vistra
Fortrea falls after downbeat 2026 outlook
Fortrea Q4 revenue slightly misses
Brief: Fortrea Appoints Oren Cohen As Chief Medical Officer And Scott Dove As President Of Clinical Pharmacology Services
Brief: Sctbio And Fortrea Forge Strategic Collaboration To Accelerate Cell And Gene Therapy Development And Delivery
U.S. RESEARCH ROUNDUP-Green Brick Partners, Pultegroup, Toll Brothers
Brief: Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash On Hand
Activist Starboard sells Pfizer stake after pushing for changes
Brief: Starboard Value LP Dissolves Share Stake In Pfizer & Fortrea
Contract research organization Fortrea beats Q3 revenue expectations, raises 2025 guidance
Brief: Fortrea Appoints William Sharbaugh To Board Of Directors
Brief: Fortrea Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- IQVIA Holdings, Reliance, United Therapeutics
Brief: Starboard Value Raises Stake In Pfizer And Salesforce, Cuts In News Corp
Charles River profit forecast clouded by order cancellations from biotechs (updated)